Sree Bhushan Raju

Sree Bhushan Raju M.D., D.M., Diplomate of National Board, (Telugu: శ్రీ భూషణ్ రాజు) is a nephrologist from Telangana, India. He is currently Professor and Head, Dept of Nephrology, Nizam's Institute of Medical Sciences Panjagutta, Hyderabad. Which is largest teaching Department in India having eight DM seats.[1][2] He is one of the principal investigators of CKD task force by Indian Council of Medical Research (ICMR) to evaluate the prevalence of CKD in adult urban population in India.[3]

Sree Bhushan Raju
Born
Bhongir, Nalgonda Telangana
NationalityIndian
CitizenshipIndia
Alma materGandhi Medical College
All India Institute of Medical Sciences
Nizam's Institute of Medical Sciences
AwardsVaidya Ratna
Scientific career
FieldsNephrologist
InstitutionsNizam's Institute of Medical Sciences

Early life and education

Doctor Sree Bhushan Raju was born in Vanaparthi village in a lower-middle-class background family. This village is located at Bhongir mandal of Nalgonda district of Telangana. After primary school education, he pursued medical education (MBBS) in Gandhi Medical College, Hyderabad and completed the course in 1993. He was awarded various gold medals for his academic excellence during the MBBS curriculum. He secured a top rank in All India competitive examination and joined the Nizam's Institute of Medical Sciences, Hyderabad for his post-graduation. He completed the M.D (General Medicine) at NIMS in 1998. Later he joined the prestigious All India Institute of Medical Sciences, New Delhi, India and completed the D.M. in nephrology. He scored highest marks and earned a gold medal in the D.N.B examination held in September 2002. He is one of the very few specialists with MBA in health care management in the country. Main areas of interest are clinical nephrology, CAPD, and CRRT.[3] He was also served as elected NIMS faculty association President.

Career

He has written more than 100 publications in various national and international journals and has attended conferences and workshops abroad both as a delegate and speaker/moderator since the last 15 years. He is a regular writer in popular print media and educates the public on various Kidney diseases through electronic media.[4]

Along with seeing patients daily, he specializes in kidney transplantation and Peritoneal dialysis (PD). He is known for his minimal use of immunosuppressive drugs without induction agents in organ transplantation. He has performed more than 250 kidney transplantations, 5000 renal biopsies, and 700 CAPD patients, since 2011. under his leadership and commitment, the department became one of the largest in the country with 8 faculty and 18 fellows. The department caters to 25000 new patients every year and active inpatient care (around 600 real biopsies, 100 renal transplants including an active deceased donor transplant program, and nearly 100 PD catheter insertions, every year) as well as clinical research.[3] He has conducted regular free medical camps for the people of his village and surrounding villages. He extended his service by providing basic amenities to the nephrology departments like renovation of the ARCU and other essential things for patients.

He advocates that Peritoneal dialysis is ideal for kidney patients who find it difficult to travel to hospitals. Currently the nephrology department of NIMS — the largest peritoneal dialysis centre in the country – trains 80 patients to 100 patients every year in the procedure. NIMS Hospital has become the first centre in South India to receive recognition from the International Society of Peritoneal Dialysis (ISPD) as a training centre for peritoneal dialysis. The efficient training and treatment protocols employed for patients made the department the only centre in South India to bag ISPD's recognition.[5]

Patients need a bit of hand-holding in the initial two to three months. After that, they really benefit. The peritoneal dialysis is ideal for kidney patients who find it difficult to travel to hospitals for Certain categories of patients such as children, elderly and visually impaired, who cannot travel long distances, need peritoneal dialysis support at home. Almost all the major private hospitals provide hemodialysis, wherein dialysis machines are used to purify the blood for kidney patients and are located in hospitals. In peritoneal dialysis, patients usually can take care of themselves at home and do not need a dedicated bedside healthcare provider. says Sree Bhushan Raju[5]

Awards and recognition
  • FISOT : Fellowship of Indian Society of Organ Transplantation 2017[6]
  • FICP : Indian College of Physicians Association of Physicians of India, January 2012.
  • FIACM : Fellowship of Indian Association of Clinical Medicin(IACM), October 2012.
  • FISN : Fellowship of Indian Society of Nephrology(ISN), December 2012.[7]

publications
  • Goli R; Raju SB; Uppin MS (May 2018). "Monoclonal Gammopathy of Renal Significance Presenting as Cryoglobulinemic Glomerulonephritis: A Case Report and Review of Literature". Indian Journal of Nephrology. 28 (3): 229–231. doi:10.4103/ijn.IJN_166_16. PMC 5998724. PMID 29962675.
  • Post renal transplant diabetes mellitus and hepatitis C: Is there any association. Raju DSB, Agarwal SK, Gupta S, Dash SC, Bhowmick D, Tiwari SC, Guleria S, Mehta SN. Presented as poster in Congress Asian Society of Transplantation (CAST), 2002 held at New Delhi.
  • Post-transplant hypertension at one year: Impact on long-term graft survival. Raju DSB, Agarwal SK, Gupta S, Dash SC, Bhowmick D, Tiwari SC, Guleria S, Mehta SN. Presented as poster in Congress Asian society of Transplantation (CAST), 2002 held at New Delhi.
  • Prevalence of CRF in India. Agarwal SK, Dash SC, Raju DSB, Irshad M. Presented in racial and ethnic minority groups, official satellite conference in the world congress of Nephrology, 18–20 October 2001, Santaffi, USA.
  • Prevalence of chronic renal failure in adults in Delhi, India. Agarwal SK, Dash SC, Irshad M, Raju S, Singh R, Pandey RM, Nephrol Dial Transplant. 2005 Aug; 20 (8): 1638–42.
  • Rituximab in the treatment of refractory late acute antibody-mediated rejection: Our initial experience. Surendra M, Raju SB, Raju N, Chandragiri S, Mukku KK, Uppin MS. Indian J Nephrol. 2016 Sep;26(5):317-321
  • Revisiting renal amyloidosis with clinicopathological characteristics, grading, and scoring: A single-institutional experience. Kalle A, Gudipati A, Raju SB, Kalidindi K, Guditi S, Taduri G, Uppin MS.J Lab Physicians. 2018 Apr-Jun;10(2):226-231.
  • Management of statin intolerance. Raju SB, Varghese K, Madhu K. Indian J Endocrinol Metab. 2013 Nov;17(6):977-82. doi: 10.4103/2230-8210.122602
gollark: I mean, my phone has a *navbar* most of the time, so I imagine that counts.
gollark: It's probably partly determined by use, but someone here mentioned problems with burn in earlier this very day.
gollark: Don't care.
gollark: Burn in and lower efficiency some of the time.
gollark: OLED is kind of awful.

References
  1. "Hospitals & Clinics". Pharmabiz.com. 20 November 2017. Retrieved 8 September 2019.
  2. "Academic council". NIMS. 20 March 2018. Retrieved 3 September 2019.
  3. "the ISN articles". TheISN.org. 20 June 2017. Retrieved 3 September 2019.
  4. "The Hindu". The Hindu. 10 April 2018. Retrieved 8 September 2019.
  5. "Hyderabad: NIMS simplifies dialysis with at-home procedure". Telangana Today. 3 September 2017. Retrieved 3 August 2019.
  6. "Awards & Honour". ISOT.co.in. 2017. Retrieved 9 August 2019.
  7. "fellows_of_isn". ISN India. 22 March 2012. Retrieved 7 October 2018.
This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.